Virtual Medicinal Product (VMP) - Daclatasvir 30mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Daclatasvir 30mg tablets Start Date 03-09-2014 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
J05AP07
BNF Start Date End Date
Current BNF 05030302 Start Date 04-04-2022 End Date
Previous BNF 05030302 Start Date 14-01-2015 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
26941111000001108 03-09-2014

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Daclatasvir dihydrochloride Based on Base Substance Daclatasvir 30 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet